Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis

July 1, 2026 updated by: Waldfriede Hospital

Clinical Outcomes of Scapholunate Ligament Reconstruction Using Modified Flexor Carpi Radialis Tenodesis - A Retrospective Study From 2016-2026

Retrospective study of patients who underwent a modified flexor carpi radialis (FCR) tenodesis for scapholunate ligament injury at Waldfriede Hospital during the period 2016-2026.

Primary outcome: Functionality of the operated wrist measured using the validated DASH questionnaire.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Germany
    • State of Berlin
      • Berlin, State of Berlin, Germany, 14163
        • Recruiting
        • Waldfriede Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participation in the study is offered to all eligible patients who underwent a modified flexor carpi radialis (FCR) tenodesis for an SL ligament injury at Waldfriede Hospital between 2016 and 2026.

Description

Inclusion Criteria:

  • Age: ≥ 18 years
  • Capable of providing informed consent independently
  • Availability of written informed consent for the study

Exclusion Criteria:

  • Active malignant disease
  • Pregnancy at the time of the examination
  • Presence of SLAC arthritis
  • Lack of capacity to provide independent consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
DISABILITIES OF THE ARM, SHOULDER AND HAND (DASH) questionnaire
Time Frame: At enrollment
DISABILITIES OF THE ARM, SHOULDER AND HAND; This questionnaire asks about symptoms as well as the ability to do certain activities regarding the upper limbs. Measure uses a 0 to 100 scoring scale, where lower scores (close to 0) represent no disability, and higher scores (close to 100) indicate maximum severity or inability to perform.
At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Waldfriede Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2026

Primary Completion (Estimated)

January 31, 2027

Study Completion (Estimated)

May 31, 2027

Study Registration Dates

First Submitted

June 18, 2026

First Submitted That Met QC Criteria

June 18, 2026

First Posted (Actual)

June 24, 2026

Study Record Updates

Last Update Posted (Actual)

July 2, 2026

Last Update Submitted That Met QC Criteria

July 1, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • BB 112/26

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Data must remain within the clinic, and we are not permitted to share the raw data publicly or upon request with external researchers as this is the standard practice for retrospective data due to data protection/GDPR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Scapholunate Dissociation

Clinical Trials on modified flexor carpi radialis tenodesis

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe